Loading stock data…
$12.40-0.57 (-4.39%)
Kardigan, Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — |
| Operating Income | -$75.23M↓ | -$58.71M↓ | -$57.13M↓ | -$26.08M |
| Net Income | -$116.24M↓ | -$56.07M↑ | -$57.45M↓ | -$18.02M |
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, incl...